Episode Chapters
- Introduction: Impacted CerumenFree Chapter8:22Happy New Year!1:03Palliative Care Emergencies30:59Paper Chase 1: Empagliflozin and Mortality in Type 2 Diabetic Patients7:15Vaginitis Update19:53Paper Chase 2: Endoscopic Therapy Improves Resolution of Dysplasia for Patients6:19Zombie Insects2:40A Primer on Serum Protein Electrophoresis (SPEP)17:54Paper Chase 3: CEA vs Medical Therapy for Asymptomatic Severe Carotid Stenosis5:00Testing for Occult Malignancy in the Patient with an Unprovoked DVT or PE14:05The Happy MD’s Guide to Physician Wellness18:38Is Your Cat Making You a Zombie?2:52Paper Chase 4: The Brief Memory and Executive Test4:08Short Stature30:01Zombie Dancing4:47Paper Chase 5: Vulvovaginal Swabs or Endocervical Swabs5:55The Summary14:44
Patients with type 2 diabetes at high risk for cardiovascular events who received empagliflozin, as compared with placebo, had a lower rate of the primary composite cardiovascular outcome and of death from any cause when the study drug was added to standard care.
Palliative Cerumen Emergencies Full episode audio for MD edition 194:36 min - 91 MB - M4AHippo Primary Care RAP January 2016 Summary 1 MB - PDF